Precipitation of acute coronary syndrome in an interactive association of oxidative stress biomarkers with soluble receptor for advanced glycation end-products

References

• Sugiyama T, Yamamoto E, Fracassi F, et al. Calcified plaques in patients with acute coronary syndromes. J Am Coll Cardiol 2019;12(6):531–540. doi:10.1016/j.jcin.2018.12.013
   Google Scholar
• Fracassi F, Crea F, Sugiyama T, et al. Healed culprit plaques in patients with acute coronary syndromes. J Am Coll Cardiol 2019;73(18):2253–2263. doi:10.1016/j.jacc.2018.10.093
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arteriosclerosis Thrombosis Vascular Biol. 2010;30(7):1282–1292. doi:10.1161/ATVBAHA.108.179739
   PubMed Web of Science ®Google Scholar
• Keaney JF Jr., Vita JA. The value of inflammation for predicting unstable angina. N Engl J Med 2002;347(1):55–57. doi:10.1056/NEJM200207043470112
   PubMed Web of Science ®Google Scholar
• Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation. 2003;107(16):2072–2075. doi:10.1161/01.CIR.0000069329.70061.68
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874. doi:10.1038/nature01323
   PubMed Web of Science ®Google Scholar
• Burke AP, Kolodgie FD, Farb A, et al. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002;105(3):297–303. doi:10.1161/hc0302.102610
   PubMed Web of Science ®Google Scholar
• van Haelst PL, Cohen Tervaert JW, Bijzet J, et al. Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation. Clin Exp Immunol 2004;138(2):364–368. doi:10.1111/j.1365-2249.2004.02602.x
   PubMed Web of Science ®Google Scholar
• Alam SE, Nasser SS, Fernainy KE, et al. Cytokine imbalance in acute coronary syndrome. Curr Opin Pharmacol. 2004;4(2):166–170. doi:10.1016/j.coph.2003.10.011
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–1143. doi:10.1161/hc0902.104353
   PubMed Web of Science ®Google Scholar
• Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001;88(10):998–1003. doi:10.1161/hh1001.090571
   PubMed Web of Science ®Google Scholar
• Elahi MM, Matata BM. Free radicals in blood: evolving concepts in the mechanism of ischemic heart disease. Arch Biochem Biophys 2006;450(1):78–88. doi:10.1016/j.abb.2006.03.011
   PubMed Web of Science ®Google Scholar
• Serdar Z, Serdar A, Altin A, et al. The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes. Acta Cardiol. 2007;62(4):373–380. doi:10.2143/AC.62.4.2022281
   PubMed Web of Science ®Google Scholar
• Alderman CJ, Shah S, Foreman JC, et al. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 2002;32(5):377–385. doi:10.1016/S0891-5849(01)00735-3
   PubMed Web of Science ®Google Scholar
• Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, et al. Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome. PLoS One. 2013;8(9):e74302, doi:10.1371/journal.pone.0074302
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Witztum J. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation. 2001;103(15):1930–1932. doi:10.1161/01.CIR.103.15.1930
   PubMed Web of Science ®Google Scholar
• Hamasaki MY, Barbeiro HV, de Souza HP, et al. sRAGE in septic shock: a potential biomarker of mortality. Rev Bras Terapia Intensive. 2014;26(4): doi:10.5935/0103-507X.20140060
   Google Scholar
• Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, et al. Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: new roles for soluble RAGE. Eur J Heart Fail 2010;12(10):1092–1100. doi:10.1093/eurjhf/hfq117
   PubMed Web of Science ®Google Scholar
• Shimomura M, Oyama JI, Takeuchi M, et al. Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial). Heart Vessels. 2016;31(10):1583–1589. doi:10.1007/s00380-015-0773-y
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Takino J, Yamagishi S. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr Drug Targets. 2010;11(11):1468–1482. doi:10.2174/1389450111009011468
   PubMed Web of Science ®Google Scholar
• Volz HC, Laohachewin D, Seidel C, et al. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling. Basic Res Cardiol 2012;107(2):250, doi:10.1007/s00395-012-0250-z
   PubMed Web of Science ®Google Scholar
• Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70(2):181–190. doi:10.1016/j.cardiores.2006.02.025
   PubMed Web of Science ®Google Scholar
• Vichova T, Motovska Z. Oxidative stress: predictive marker for coronary artery disease. Exp Clin Cardiology. 2013;18(2):88, PMID: 23940453; PMCID: PMC3718605.
   PubMedGoogle Scholar
• Varadarajan SG, An J, Novalija E, et al. Changes in [Na+], compartmental [Ca2+], and NADH with dysfunction after global ischemia in intact hearts. Am J Physiol Heart Circ Physiol 2001;280(1):H280–H293. doi:10.1152/ajpheart.2001.280.1.H280
   PubMed Web of Science ®Google Scholar
• Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 2008;81(3):482–490. doi:10.1093/cvr/cvn333
   PubMed Web of Science ®Google Scholar
• Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2008;81:457–464. doi:10.1093/cvr/cvn335
   PubMed Web of Science ®Google Scholar
• Ito H. No-reflow phenomenon in patients with acute myocardial infarction: Its pathophysiology and clinical implications. Acta Med Okayama. 2009;63(4):161–168. doi:10.18926/AMO/31817
   PubMed Web of Science ®Google Scholar
• Sigala F, Kotsinas A, Savari P, et al. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J Vasc Surg 2010;52(3):704–713. doi:10.1016/j.jvs.2010.03.047
   PubMed Web of Science ®Google Scholar
• Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103(15):1955–1960. doi:10.1161/01.CIR.103.15.1955
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Libuy M, Feliú F, et al. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers. 2013;35(6):773–790. doi:10.1155/2013/974358
   PubMed Web of Science ®Google Scholar
• Lubrano V, Pingitore A, Traghella I, et al. Emerging biomarkers of oxidative stress in acute and stable coronary artery disease: levels and determinants. Antioxidants. 2019;8(5):115, doi:10.3390/antiox8050115
   Web of Science ®Google Scholar
• Bastani A, Rajabi S, Daliran A, et al. Oxidant and antioxidant status in coronary artery disease. Biomed Rep. 2018;9(4):327–332. doi:10.3892/br.2018.1130
   PubMed Web of Science ®Google Scholar